The collaboration is non-exclusive and lacks disclosed financial terms, so near-term revenue impact is uncertain. Monitor for any future revenue-sharing agreements or expansion of the Radial Health network that could drive adoption of BrainsWay's devices.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $11.09entry
- T+1 · 14d ago +0.54%α +0.24% · $11.15
- T+5 · 8d ago +4.96%α +4.88% · $11.64
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BrainsWay announced a strategic collaboration with Mindful Health Solutions (MHS), whose managed services organization was acquired by Radial Health, to expand patient access to BrainsWay's Deep TMS and accelerated SWIFT treatment protocol, and explore integration of Neurolief's ProlivRx at-home therapy. The collaboration includes joint physician education and research initiatives. BrainsWay also disclosed a recent $0.8M follow-on equity investment in the management services organization servicing the Heading Health clinic network.
Key Facts
- BrainsWay entered a strategic collaboration with Mindful Health Solutions (MHS), now part of Radial Health, which operates 27 brain medicine clinics across 7 US states.
- The collaboration aims to expand patient access to BrainsWay Deep TMS and accelerated SWIFT treatment protocol, and explore integration of Neurolief's ProlivRx at-home neuromodulation therapy.
- BrainsWay made a follow-on equity investment of $0.8M in the management services organization servicing the Heading Health clinic network.
- No financial terms of the collaboration were disclosed.
Financial Impact
No deal value disclosed; BrainsWay's $0.8M investment in Heading Health is small relative to its $479M market cap (0.17%).
Risk Factors
- No financial terms disclosed; collaboration may not generate material revenue.
- Forward-looking statements caution that investments in management services organizations may not produce profitable returns.
- Competition from other TMS and neuromodulation providers could limit adoption.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3393040 |
Track record
24 reports on BWAY
6 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +27.55% at T+60 after the Mar 4, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 10, 20266d ago 6-K Bullish 6/10 No price data
- Nov 10, 20266d ago 6-K Neutral 5/10 Entry $10.67 Now $9.39 −12.00% settles Dec 9
- Nov 2, 202614d ago 6-K Neutral 3/10 Entry $11.09 Now $9.39 −15.33% settles Dec 1
- Nov 2, 202614d ago Press Release Neutral 3/10 Viewing Entry $11.09 Now $9.39 −15.33% settles Dec 1
- Oct 26, 202621d ago 6-K Neutral 3/10 Entry $11.21 Now $9.39 −16.24% settles Nov 23
- Oct 21, 202626d ago 6-K Neutral 3/10 Entry $11.44 Now $9.39 −17.92% settles Nov 19
- Oct 19, 202628d ago 6-K Neutral 3/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
- Oct 19, 202628d ago Press Release Neutral 4/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
- Oct 13, 20264w ago 6-K Neutral 4/10 Entry $11.92 to $10.67 Now $9.39 −21.22% ▼ −10.49% −6.88% vs SPY
- Sep 8, 20269w ago 6-K Neutral 4/10 Entry $14.16 to $11.89 Now $9.39 −33.69% ▼ −16.03% −18.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers